Genworth Financial (GNW) has reshaped its long term care footprint by ending new LTC insurance sales through its legacy unit and launching CareScout Insurance, which offers a new product available in 40 states.

Against this backdrop of reshaping its long term care offerings, Genworth Financial’s share price at $8.97 reflects modest recent moves, with a 90 day share price return of 12.41% and a 1 year total shareholder return of 15.30%. The 3 and 5 year total shareholder returns of 77.62% and 125.38% suggest longer term investors have seen materially stronger outcomes than short term traders.

If Genworth’s repositioning has you thinking about where else value might emerge, this can be a good moment to broaden your search with the 20 top founder-led companies

With Genworth Financial stock trading at $8.97, a value score of 0 and analyst targets implying a gap to $11.00, the key question is whether investors are overlooking potential or the market is already pricing in future growth.

Price to Earnings of 16.3x: Is it justified?

Genworth Financial stock closed at $8.97, and on a P/E of 16.3x it currently trades at a richer earnings multiple than many insurance peers.

The P/E multiple compares the company’s share price to its earnings per share, so a higher P/E usually reflects investors paying more for each unit of current earnings.

For Genworth Financial, that higher price tag sits alongside earnings that declined 7.5% over the past year and a net margin of 2.9%. Earnings are also forecast to decline on average over the next three years. That mix raises the question of whether the market is giving the stock a premium that is hard to reconcile with recent and expected profit trends.

Against the US Insurance industry, where the average P/E is 11.3x, Genworth Financial’s 16.3x multiple is materially higher. It is also well above an estimated fair P/E of 6.6x, a level the market could move toward if sentiment shifts and investors decide to pay closer to what the fair ratio suggests for this level of earnings power.

Result: Price-to-Earnings of 16.3x (OVERVALUED)

However, Genworth Financial’s reliance on its Enact and Closed Block segments, along with declining annual net income growth, could pressure earnings and challenge the current valuation narrative.

Another View on Genworth Financial Using Our DCF Model

While the P/E discussion suggests Genworth Financial stock is trading rich versus peers and the fair ratio, the discounted cash flow view is even more cautious. At $8.97, our DCF model points to a future cash flow value of about $1. This frames the shares as clearly overvalued on this measure. If the market leans more on cash generation than earnings multiples, how much weight should this signal carry in your own process?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Genworth Financial for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 48 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If this mix of signals around Genworth Financial feels mixed to you, that is exactly why it pays to review the data in full and decide quickly where you stand. Start with the 1 key reward and 2 important warning signs.

Looking for more investment ideas beyond Genworth Financial?

If Genworth Financial has sharpened your focus on valuation and risk, do not stop here. Broaden your watchlist now so you do not overlook your next opportunity.

• Target value by scanning for companies that combine quality with attractive pricing using the 48 high quality undervalued stocks.
• Strengthen your core holdings by focusing on companies with robust finances through the solid balance sheet and fundamentals stocks screener (48 results).
• Spot underfollowed opportunities early by reviewing the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.